newsfilter
← Latest News
PR Newswire·

AbbVie Completes Acquisition of ImmunoGen

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of ImmunoGen (NASDAQ: IMGN). With the completion of the acquisition,...